Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Omega Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19
   10-K10-KS-1
Revenues  0.10.011.9
            Revenue growth   -100.0% 
Cost of goods sold  0.00.017.3
Gross profit  0.10.0-5.4
            Gross margin  100.0% -45.3%
Selling, general and administrative   [+]16.66.24.2
Research and development  47.921.1 
Other operating expenses  1.71.37.7
EBITDA   [+]-64.6-27.5-16.5
            EBITDA margin  -44892.4% -138.7%
Depreciation and amortization  1.41.10.8
EBIT   [+]-66.0-28.6-17.3
            EBIT margin  -45855.6% -145.3%
Interest expense  0.90.80.6
Other income (expense), net   [+]-1.30.017.9
Pre-tax income  -68.3-29.40.0
Income taxes  0.00.00.0
            Tax rate  0.0%0.0% 
Net income  -68.3-29.40.0
            Net margin  -47416.7% 0.0%
   
Basic EPS   [+]($3.05)($7.54) 
Diluted EPS   [+]($3.05)($7.54) 
   
Shares outstanding (basic)   [+]22.43.9 
Shares outstanding (diluted)   [+]22.43.9 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy